SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-007505
Filing Date
2024-02-22
Accepted
2024-02-22 09:05:37
Documents
21
Period of Report
2024-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 56386
2 ex10-1.htm EX-10.1 25404
3 ex10-2.htm EX-10.2 16405
4 ex10-3.htm EX-10.3 19903
5 ex10-4.htm EX-10.4 20082
6 ex10-5.htm EX-10.5 20197
7 ex10-6.htm EX-10.6 20195
  Complete submission text file 0001493152-24-007505.txt   421771

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE celu-20240216.xsd EX-101.SCH 3872
9 XBRL DEFINITION FILE celu-20240216_def.xml EX-101.DEF 26769
10 XBRL LABEL FILE celu-20240216_lab.xml EX-101.LAB 37000
11 XBRL PRESENTATION FILE celu-20240216_pre.xml EX-101.PRE 25393
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5923
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 24662490
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)